Company News
Organon Up 8.4% After Sun Pharma Offer
Organon’s stock rose 8.4% to $7.49 in pre‑market trading after reports of Sun Pharma’s $12 billion binding bid.
Sun Pharmaceutical Industries has completed three months of due diligence and is finalis
